Hepatitis B Screening and Confirmatory Testing Protocol
Screen all adults at least once using a triple panel test (HBsAg, anti-HBs, and anti-HBc), and confirm any initially reactive HBsAg result with an FDA-approved confirmatory neutralization test before diagnosing chronic hepatitis B infection. 1
Screening Approach
The most recent CDC 2023 guidelines recommend universal screening for all adults ≥18 years at least once in their lifetime using three tests simultaneously 1:
- Hepatitis B surface antigen (HBsAg) - detects active infection
- Antibody to hepatitis B surface antigen (anti-HBs) - indicates immunity from vaccination or resolved infection
- Antibody to hepatitis B core antigen (anti-HBc) - indicates past or current infection
This triple panel approach is superior to HBsAg-only screening because it provides complete information about infection status, immunity, and vaccination needs in a single draw 2, 3.
High-Risk Groups Requiring Periodic Screening
For patients with ongoing risk factors who test negative initially, repeat screening periodically 4:
- Persons who inject drugs (current or past)
- Men who have sex with men
- Persons with HIV infection
- Household contacts or sexual partners of HBsAg-positive persons
- Persons born in countries with HBV prevalence ≥2%
- Persons with hepatitis C infection
- Incarcerated or formerly incarcerated persons
- Persons with history of sexually transmitted infections
- Persons requiring immunosuppressive therapy
- Hemodialysis patients
Confirmatory Testing Protocol
Any initially reactive HBsAg result MUST be confirmed with an FDA-approved neutralization test before making a diagnosis 4. This is critical because false-positive rates have increased with more sensitive modern immunoassays.
When Confirmatory Testing is Essential:
The positive predictive value of initial HBsAg screening varies dramatically by population. Research shows that among young vaccinated populations, only 56% of initial HBsAg-positive results are true positives 5. The confirmatory test works by treating the sample with neutralizing antibodies—if the signal decreases by ≥40% (to ≤60% of the original value), the result is confirmed positive 6.
Practical Algorithm for Confirmation:
- Initial HBsAg positive with cutoff index (COI) ≥6.0: Likely true positive, but still perform confirmatory test 6
- Initial HBsAg positive with COI 0.9-6.0: Mandatory confirmatory testing—approximately 30% will be false positives 6
- Confirmed positive: Proceed with serologic panel interpretation and linkage to hepatology care
- Confirmed negative: Consider patient vaccinated or with resolved infection; check anti-HBs and anti-HBc for clarification
Critical Pitfalls to Avoid
Do not diagnose chronic hepatitis B based on a single positive HBsAg without confirmatory testing. This is especially important in:
- Young adults born after universal vaccination programs began (post-1991 in the U.S.)
- Populations with low HBV prevalence
- Patients with low COI values on initial screening
The failure to confirm can lead to unnecessary anxiety, inappropriate specialist referrals, stigmatization, and potential treatment of patients who are not actually infected 5.
After Confirmation
Once HBsAg is confirmed positive, the complete serologic panel allows differentiation between acute and chronic infection, and guides management decisions. All confirmed HBsAg-positive patients require referral to hepatology for treatment evaluation, monitoring, and hepatocellular carcinoma surveillance 3. The major implementation gap occurs between diagnosis and clinical engagement—only 35-59% of diagnosed patients successfully link to care 7, making post-diagnosis navigation and follow-up essential.